Fortress Biotech (FBIO) Long-Term Investments (2014 - 2026)

Fortress Biotech's Long-Term Investments history runs 10 years deep, the most recent figure standing at $17.7 million for Q4 2025.

• In Q4 2025, Long-Term Investments rose 583.17% year-over-year to $17.7 million; the TTM figure through Dec 2025 stood at $17.7 million (up 583.17% YoY), while the FY2025 annual figure was $17.7 million, up 583.17% from the prior year.
• Long-Term Investments for Q4 2025 stood at $17.7 million, up from $2.6 million in the prior quarter.
• The five-year high for Long-Term Investments was $56.9 million in Q3 2021, with the low at $2.6 million in Q4 2024.
• The 3-year median for Long-Term Investments is $23.5 million (2021), against an average of $29.8 million.
• The sharpest annual moves came in 2021 and 2025: Long-Term Investments soared 110.61% in 2021, then jumped 583.17% in 2025.
• Fortress Biotech's Long-Term Investments stood at $56.9 million in 2021, then sank by 95.45% to $2.6 million in 2024, then surged by 583.17% to $17.7 million in 2025.
• Business Quant data shows FBIO's Long-Term Investments at $17.7 million in Q4 2025, $2.6 million in Q4 2024, and $56.9 million in Q3 2021.